Cramer's 'Mad Money' Recap: Slim's Pickins

Cramer asked Quay about Nastech's relationship with Dr. Eric Hollander, who has been involved with autism.

"He has shown by giving intravenous doses of a natural hormone, oxytocin, that you can reverse some of the signs of autism," Quay said of Hollander. But there are two problems related to it: "It's an injection and doesn't last long enough."

On the other hand, Nastech, the CEO said, has a nasal spray that lasts "a significantly longer period of time." Nastech has been "working closely" with Hollander "to design clinical trials this year to test the nasal spray," Quay said.

Cramer said he likes Nastech, along with Celgene (CELG), Gilead Sciences (GILD) and Genzyme (GENZ).

To view Cramer's interview with Steven Quay, please click here.

Lightning Round

Cramer was bullish on Downey Financial (DSL), Nokia (NOK), Apple (AAPL), Quicksilver Resources (KWK), XTO Energy (XTO), Procter & Gamble (PG), RPM International (RPM), St. Jude Medical (STJ), Dow Chemical (DOW), Google (GOOG), Domino's Pizza (DPZ), Diageo (DEO), Broadridge Financial (BR), Tiffany (TIF), Coach (COH), Polo Ralph Lauren (RL) and Guess? (GES).

Cramer was bearish on Companhia Vale do Rio Doce (RIO), BHP Billiton (BHP), TrustCo Bank Corp (TRST), Motorola (MOT) and Southern Copper (PCU).

For more of Cramer's insights during the Lightning Round, click here.

---

Want more Cramer? Check out Jim's rules and commandments for investing from his popular book by clicking here.

>To order reprints of this article, click here: Reprints